Abalam-Power (Abacavir and Lamivudine Tablet) 600mg/300mg

ABALAM-POWER is a prescription combination antiretroviral medication containing the active ingredients abacavir (600mg) and lamivudine (300mg) in a single oral tablet. Classified as Nucleoside Reverse Transcriptase Inhibitors (NRTIs), these active substances work together to inhibit the HIV reverse transcriptase enzyme, preventing viral replication. It is used in combination with other antiretroviral agents for the management of human immunodeficiency virus type 1 (HIV-1) infection.

Strength

600mg/300mg

Pack Size

30s

Storage

Ambient

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ABALAM-POWER is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 25 kg. By reducing the viral load and increasing CD4 cell counts, this medication helps manage HIV-1 infection, though it is not a cure for HIV or AIDS.

Side Effects

Common side effects of ABALAM-POWER include nausea, headache, fatigue, insomnia, diarrhea, and dizziness. Serious adverse reactions can occur, most notably a severe and potentially life-threatening hypersensitivity reaction associated with the abacavir component, as well as lactic acidosis and severe hepatomegaly with steatosis.

Precautions & Warnings

Prior to initiating ABALAM-POWER, patients must be screened for the HLA-B*5701 allele, as individuals carrying this genetic marker are at a high risk of experiencing a severe hypersensitivity reaction to abacavir. Additionally, patients co-infected with hepatitis B virus (HBV) should be closely monitored, as discontinuation of lamivudine may trigger acute exacerbations of hepatitis B. This medication is classified under Pregnancy Category C and should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.

Avoid Interactions

ABALAM-POWER may interact with other medications, including alcohol (which can increase abacavir levels), sorbitol-containing medicines, and other antiretrovirals like zalcitabine or emtricitabine. It is important to consult a healthcare provider before taking any concurrent prescription drugs, over-the-counter medications, or herbal supplements to avoid adverse drug interactions.

Frequently Asked Questions

ABALAM-POWER is a prescription antiretroviral tablet used in combination with other medications to treat human immunodeficiency virus type 1 (HIV-1) infection.

Each ABALAM-POWER tablet contains a combination of two active ingredients: 600mg of abacavir and 300mg of lamivudine.

Genetic testing for the HLA-B*5701 allele is required before starting ABALAM-POWER because patients with this gene have a significantly higher risk of a severe, potentially life-threatening hypersensitivity reaction to the abacavir component.

If you develop symptoms of a hypersensitivity reaction, such as fever, rash, nausea, vomiting, abdominal pain, extreme tiredness, or respiratory issues, stop taking the medication immediately and seek emergency medical attention. Do not restart the drug.

No, ABALAM-POWER does not cure HIV-1 or AIDS. It helps control the virus by lowering the viral load in the body, which supports the immune system, but patients must continue their prescribed treatment plan as directed by their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.